Protara Therapeutics Inc
Biotechnology
Healthcare
TARA
22.33 M shares
NASDAQ US
traded
14 Apr 2025
listed
no
open
3.99
52 week high
6.67
high
4.25
52 week low
1.62
low
3.93
growth
55.06 %
previous Close
3.91
P/E ratio
market cap
189 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-11.22 M
-17.93 %
eps
0.00 %
-11.64 %
eps surprise
3.38 %
net profit margin
-1121900000.00 %
0.00 %
operating incoming
-12.33 M
-15.66 %
net change in cash
-37.82 M
-201.27 %
cash on hand
51.76 M
-42.22 %
cost of revenue
0.00 %
top top